Gilsbar’s self-funded clients will have access to Regenexx nonsurgical procedures. Regenexx believes its procedures can treat 70 percent of all orthopedic injuries and conditions at more affordable rates than surgery.
More articles on orthopedics:
Hospital for Special Surgery gets $3M grant for pain management research, physician education
CarboFix to launch carbon fiber vertebral body replacement device
Xtant Medical launches 3 new spinal implants — 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
